Voltar
Artigo Revisado por pares
BIBTEX RIS

Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial

2013; Springer Science+Business Media; Volume: 20; Issue: 12 Linguagem: Inglês

10.1245/s10434-013-3129-9

ISSN

1534-4681

Autores

Fuyuhiko Motoi, Kazuyuki Ishida, Fumiyoshi Fujishima, Shigeru Ottomo, Masaya Oikawa, Takaho Okada, Hiromune Shimamura, Shinichi Takemura, Fuminori Ono, Masanori Akada, Kei Nakagawa, Yu Katayose, Shinichi Egawa, Michiaki Unno,

Tópico(s)

Cancer Genomics and Diagnostics

Referência(s)